| 摘要 |
The presence of oxidative stress in a patient is determined by immobilizing plasma proteins onto a support, derivatizing any oxidized proteins with 2,4-dinitrophenylhydrazine (DNPH}, contacting the derivatized plasma proteins with anti-DNPH antibody, then measuring the amount of immunocomplex formed. In a preferred embodiment, the plasma proteins are bound to a membrane, derivatized with DNPH, contacted with anti-DNPH antibody, with the amount of immunocomplex formed being determined by contacting the immunocomplex with a second antibody labeled with horseradish peroxidase in conjunction with chemiluminescence. |
